Therefore, the aim of this study was to elucidate the mechanisms of HL caused by GSDME mutations at the organism and cellular levels and provide insight into new therapeutic strategies to mitigate the cytotoxicity of GSDME mutation-driven hearing impairment. This evidence concerns the gene GSDME and Hodgkins lymphoma.